Immunic Therapeutics logo

Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases

91 employees · est. 2016 · United States

VS
OD-OS Inc logo

OD-OS Inc

Navilas® - the only navigated retina laser for non-contact focal and PRP treatment plus micro second pulse option.

43 employees · est. 2008 · Irvine, United States

OD-OS Inc is the older company (2016 vs 2008); Immunic Therapeutics is the larger of the two.

Side-by-Side Comparison

Immunic Therapeutics OD-OS Inc
Founded
2016 2008 older
Headquarters
United States Irvine, United States
Employees
91 larger 43
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology, Health Care
Funding Stage
Post Ipo Equity Not tracked yet
Total Funding
$520.00M Not tracked yet
Funding Rounds
10 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Small Molecule Therapies, Chronic Inflammatory Diseases, Autoimmune Diseases, Clinical Pipeline, Oral Administration, Nasdaq Listed, Drug Development, Precision Medicine, Pharmaceuticals, Immunology, Autoimmune Disorders Retina, Ophthalmology, Medical Lasers, Therapeutic Solutions, Retina Navigation, Non-contact Treatment, PRP Treatment, Micro Second Pulse, Innovative Technology, Global Leader, Retina Diseases, Innovation, Patient Care
Website
imux.com od-os.com
Immunic Therapeutics logo

About Immunic Therapeutics

Immunic Therapeutics is a biotechnology company founded in 2016 and headquartered in the United States. The company's focus lies in the development of small molecule therapies for chronic inflammatory and autoimmune diseases. Immunic, listed on Nasdaq under the ticker symbol IMUX, boasts a clinical...

OD-OS Inc logo

About OD-OS Inc

OD-OS Inc is a biotechnology and healthcare company, founded in 2008, that focuses on setting new standards of care for retina treatment. Its flagship product, Navilas®, is the only navigated retina laser for non-contact focal and PRP treatment plus microsecond pulse option. The company aims to beco...

We will tell you when either one moves

BounceWatch watches Immunic Therapeutics and OD-OS Inc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Immunic Therapeutics and OD-OS Inc — by email.

Frequently Asked Questions

Immunic Therapeutics — Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases. OD-OS Inc — Navilas® - the only navigated retina laser for non-contact focal and PRP treatment plus micro second pulse option. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Immunic Therapeutics has raised $520.00M while OD-OS Inc has raised undisclosed funding.
Immunic Therapeutics and OD-OS Inc operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Immunic Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Immunic Therapeutics on 9 Jun 2026, and OD-OS Inc on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy